Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma

BMC Clinical Pathology

Volumn 13, Issue 1, 2013, Pages

  Denadai, Marcos Va ^a,b   Viana, Luciano S ^a,b   Affonso, Renato J ^a,b   Silva, Sandra R ^a,b   Oliveira, Indhira D ^a   Toledo, Silvia R ^a   Matos, Delcio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

Colorectal carcinoma; Extracellular matrix; Integrin

Indexed keywords

INTEGRIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR INVASION;

EID: 84878009997     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-13-16     Document Type: Article

References (36)

1. Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrix. Guest I, Uetrecht J, Med Hypotheses 1999 53 2 145 151 10.1054/mehy.1998.0734 10532710
2. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. Kram V, Zcharia E, Yacoby-Zeevi O, Metzger S, Chajek-Shaul T, Gabet Y, J Cell Physiol 2006 207 3 784 792 10.1002/jcp.20625 16514606
3. The integrin family of cell adhesion molecules has multiple functions within the CNS. Milner R, Campbell IL, J Neurosci Res 2002 69 3 286 291 10.1002/jnr.10321 12125070
4. Integrins: bidirectional, allosteric signaling machines. Hynes RO, Cell 2002 110 6 673 687 10.1016/S0092-8674(02)00971-6 12297042
5. Integrin ligands at a glance. Humphries JD, Byron A, Humphries MJ, J Cell Sci 2006 119 Pt 19 3901 3903 16988024
6. Fibronectin in malignancy. Labat-Robert J, Semin Cancer Biol 2002 12 3 187 195 10.1016/S1044-579X(02)00022-6 12083849
7. Integrins and oral cancer. Thomas GJ, Jones J, Speight PM, Oral Oncol 1997 33 6 381 388 10.1016/S0964-1955(97)00021-3 9509120
8. Integrins: a family of cell surface receptors. Hynes RO, Cell 1987 48 4 549 554 10.1016/0092-8674(87)90233-9 3028640
9. The influence of the microenvironment on the malignant phenotype. Park CC, Bissell MJ, Barcellos-Hoff MH, Mol Med Today 2000 6 8 324 329 10.1016/S1357-4310(00)01756-1 10904250
10. Integrin-associated proteins. Brown EJ, Curr Opin Cell Biol 2002 14 5 603 607 10.1016/S0955-0674(02)00360-5 12231356
11. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. Zhang Y, Lu H, Dazin P, Kapila Y, J Biol Chem 2004 279 46 48342 48349 10.1074/jbc.M407953200 15331608
12. Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. von Lampe B, Stallmach A, Riecken EO, Gut 1993 34 6 829 836 10.1136/gut.34.6.829 8314518
13. Direct integrin alphavbeta6-ERK binding: implications for tumour growth. Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum CJ, Oncogene 2002 21 9 1370 1380 10.1038/sj.onc.1205286 11857080
14. Integrins in angiogenesis and lymphangiogenesis. Avraamides CJ, Garmy-Susini B, Varner JA, Nat Rev Cancer 2008 8 8 604 617 10.1038/nrc2353 18497750
15. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Giancotti FG, Tarone G, Annu Rev Cell Dev Biol 2003 19 173 206 10.1146/annurev.cellbio.19.031103.133334 14570568
16. The role of integrins in tumor angiogenesis. Hwang R, Varner J, Hematol Oncol Clin North Am 2004 18 5 991 1006 vii 10.1016/j.hoc.2004.09.010 15474331
17. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Hoos A, Cordon-Cardo C, Lab Invest 2001 81 10 1331 1338 10.1038/labinvest.3780347 11598146
18. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Oncogene 2004 23 7 1377 1391 10.1038/sj.onc.1207262 14973550
19. The proof and measurement of association between two things. Spearman C, Int J Epidemiol 2010 39 5 1137 1150 10.1093/ije/dyq191 21051364
20. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Koivisto L, Grenman R, Heino J, Larjava H, Exp Cell Res 2000 255 1 10 17 10.1006/excr.1999.4769 10666329
21. Sensing the environment: a historical perspective on integrin signal transduction. Miranti CK, Brugge JS, Nat Cell Biol 2002 4 4 83 E90 10.1038/ncb0402-e83 11944041
22. Trafficking and cell migration. Ulrich F, Heisenberg CP, Traffic 2009 10 7 811 818 10.1111/j.1600-0854.2009.00929.x 19490534
23. Role of integrins in cancer: survey of expression patterns. Mizejewski GJ, Proc Soc Exp Biol Med 1999 222 2 124 138 10.1046/j.1525-1373.1999.d01-122.x 10564536
24. Alterations in cell-extracellular matrix interactions during progression of cancers. Jinka R, Kapoor R, Sistla PG, Raj TA, Pande G, Int J Cell Biol 2012 2012 8 Article ID 219196, http://www.hindawi.com/journals/ijcb/2012/219196/ 10.1155/2012/219196
25. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components. Haier J, Nasralla M, Nicolson GL, Br J Cancer 1999 80 12 1867 1874 10.1038/sj.bjc.6690614 10471033
26. ADAM15 to alpha5beta1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. Toquet C, Colson A, Jarry A, Bezieau S, Volteau C, Boisseau P, Int J Cancer 2012 130 2 278 287 Epub 2011 Nov 9 10.1002/ijc.25891 21190186
27. Role of beta5-integrin in epithelial-mesenchymal transition in response to TGF-beta. Bianchi A, Gervasi ME, Bakin A, Cell Cycle 2010 9 8 1647 1659 10.4161/cc.9.8.11517 20404485
28. Integrin signalling during tumour progression. Guo W, Giancotti FG, Nat Rev Mol Cell Biol 2004 5 10 816 826 10.1038/nrm1490 15459662
29. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis. Wang Y, Shenouda S, Baranwal S, Rathinam R, Jain P, Bao L, Mol Cancer 2011 10 84 PMID: 21752283 [PubMed-indexed for MEDLINE] 10.1186/1476-4598-10-84 21752283
30. The severity of neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy. Ceyhan GO, Liebl F, Maak M, Schuster T, Becker K, Langer R, Ann Surg 2010 252 5 797 804 10.1097/SLA.0b013e3181fcab8d 21037435
31. The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. Sroka IC, Anderson TA, McDaniel KM, Nagle RB, Gretzer MB, Cress AE, J Cell Physiol 2010 224 2 283 288 10.1002/jcp.22149 20432448
32. Integrins in head and neck squamous cell carcinoma invasion. Dyce OH, Ziober AF, Weber RS, Miyazaki K, Khariwala SS, Feldman M, Laryngoscope 2002 112 11 2025 2032 10.1097/00005537-200211000-00021 12439174
33. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D, Norman JC, J Cell Biol 2008 183 1 143 155 10.1083/jcb.200804140 18838556
34. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Reynolds AR, Hart IR, Watson AR, Welti JC, Silva RG, Robinson SD, Nat Med 2009 15 4 392 400 10.1038/nm.1941 19305413
35. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha[3]beta[1] and alpha[6]beta[4] integrins. Pouliot N, Nice EC, Burgess AW, Exp Cell Res 2001 266 1 1 10 10.1006/excr.2001.5197 11339819
36. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R, Cancer Res 2003 63 23 8312 8317 14678990